Bloomberg says Johnson & Johnson’s exit from the race to make a respiratory syncytial virus vaccine for adults leaves open a $10 billion market. Separately, the WHO warned that the world has “arrived in the post-antibiotic era” over a lack of development of new drugs…
Source: khn.org – Read more
Jesy Nelson celebrates rollout of screenings for rare condition
Jesy Nelson has spoken of her pride after it was announced screenings for spinal muscular atrophy will begin earlier than planned.
